BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Bio Reports

Eli Lilly Reveals Promising Phase 3 Results for Lebrikizumab in Patients with Skin of Color

Eli Lilly and Company (NYSE: LLY) announced results from a first-of-its-kind study of lebrikizumab specifically designed for people with skin of color...

March 11, 2024 | News

Visionary Titans: The Female Force Redefining the BioPharma Industry

In a domain where innovation meets executive excellence, these distinguished women infuse the biopharmaceutical industry with a blend of scientific creativ...

March 08, 2024 | News

Bayer Secures Third Consecutive Legal Victory in Roundup™ Product Liability Cases

Bayer achieved a significant milestone with its third consecutive trial victory in the Kline Roundup™ product liability trial...

March 06, 2024 | News

Sunbird Bio Advances Alzheimer's Diagnosis with APEX Blood Test, Matching PET Scan Accuracy

Sunbird Bio, a biotechnology company developing proprietary protein- and blood-based technologies to improve diagnosis and treatment of neurological disord...

March 06, 2024 | News

Bridging Gaps, Building Futures: Ruth Kuguru’s Approach to Healthcare Solutions in APAC

In this insightful interview with BioPharma APAC, Ruth Kuguru, Executive Director of Communications & Engagement at Novartis for Asia Pacific, Middle E...

March 05, 2024 | Interaction

Mastering the Regulatory Puzzle: Strategies for Biopharmaceutical Success in APAC's Diverse Landscape

The Asia-Pacific (APAC) region, with its burgeoning economies and rapidly expanding healthcare infrastructure, is a fertile ground for biopharmaceutical in...

February 20, 2024 | Regulatory

Preclinical Data Reveals Promising Long-Term Immune Response from PIV5-based Intranasal Lyme Disease Vaccine

The research showcases mice inoculated with this innovative vaccine exhibiting enduring neutralizing antibody responses, providing protection for up to 15...

February 16, 2024 | News

Cervical Cancer Screenings Drop Among Commercially Insured Women, Analysis Reveals Alarming Decline in Lifesaving Tests

The number of women getting recommended cervical cancer screenings is declining, according to data from Cedar Gate Technologies’ proprietary Nat...

January 18, 2024 | Analysis

2024 Biopharma Outlook: 24 Trends, Innovations, and FDA's Critical Role

As we step into 2024, the biopharmaceutical industry is poised for an era of unprecedented innovation and transformative breakthroughs. From cutting-edge t...

January 01, 2024 | News

Clarivate Upbeat on Pulsed-field Ablation Market's Potential Revolution

Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, today annou...

December 20, 2023 | News

Roche's Navify Digital Solutions Earn High Ratings in KLAS Research

Healthcare professionals greatly value navify Tumor Board for improving tumour board meeting experiences, offering a holistic view of data, facilita...

December 20, 2023 | News

Crown Aesthetics Reveals Groundbreaking Study on BIOJUVE™ Skin Microbiome-Optimized Regimen

Crown Aesthetics, a Crown Laboratories, Inc. company ("Crown"), announced that its groundbreaking clinical study, recently accepted for publication i...

December 14, 2023 | News

Whole Exome Sequencing Advancements in Unraveling Rare Diseases in Japan

The Rare Disease Diagnosis and Intractable Disease Research Center at Juntendo University has improved its diagnostic capabilities by combining research ...

December 11, 2023 | News

Asia Pacific Oncology Alliance Report Emphasizes Patient Collaboration for Improved Cancer Care

Report highlights fundamental shift in treatment for cancer, from a terminal to a chronic disease that can be treated and managed Expl...

December 04, 2023 | News

Stay Connected